crenolanib,gilteritinib
arog,Astellas Pharmaceuticals
['crenolanib', 'gain,stud', 'arog']
3) but luckily for the other flt3 tkis the ongoing randomized studies are comparing against 7+3+mido (precog randomized phase 2 and hovon randomized phase 3 for giltertinib+7+3 and arog randomized phase 3 study of 7+3+crenolanib) #eha2022
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK